NEW YORK, January 16, 2019 – New York Life Insurance Company announced that Robert F. Friel has joined its Board of Directors, effective as of January 1, 2019. Mr. Friel is the chairman and chief executive officer of PerkinElmer, Inc., a global leader in diagnostic and life sciences testing solutions.
Ted Mathas, chairman and chief executive officer of New York Life, said, “Robert Friel is a seasoned chief executive officer and one of the primary architects of PerkinElmer’s transformation into a global technology leader. He brings strong operational and strategic expertise and his significant financial background and corporate governance experience will benefit both the Board and New York Life overall as we work to best position the company for continued success.”
Prior to his appointment to chairman and chief executive officer of PerkinElmer, Mr. Friel served in roles of increasing responsibility that included chief operating officer, president of PerkinElmer’s Life and Analytical Sciences division, and chief financial officer.
Previous to joining PerkinElmer in 1999, Mr. Friel held several finance-focused senior management positions with AlliedSignal, Inc., now Honeywell International.
Mr. Friel currently serves on the Board of Directors of NuVasive, Inc. and Xylem Inc. He holds a Master of Science degree in taxation from Fairleigh Dickinson University and a Bachelor of Arts degree in economics from Lafayette College.
ABOUT NEW YORK LIFE
New York Life Insurance Company (www.newyorklife.com), a Fortune 100 company founded in 1845, is the largest mutual life insurance company in the United States* and one of the largest life insurers in the world. Headquartered in New York City, New York Life’s family of companies offers life insurance, retirement income, investments and long-term care insurance. New York Life has the highest financial strength ratings currently awarded to any U.S. life insurer from all four of the major credit rating agencies**.